<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1615</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2026-25-1-28-40</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lipophilicity of drugs: general characteristics and methods of determination</article-title><trans-title-group xml:lang="ru"><trans-title>Липофильность лекарственных средств: общая характеристика и методы определения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3034-750X</contrib-id><name-alternatives><name xml:lang="en"><surname>Shprakh</surname><given-names>Zoya S.</given-names></name><name xml:lang="ru"><surname>Шпрах</surname><given-names>З. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>z.shprakh@ronc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6740-5692</contrib-id><name-alternatives><name xml:lang="en"><surname>Dmitrieva</surname><given-names>Maria V.</given-names></name><name xml:lang="ru"><surname>Дмитриева</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>z.shprakh@ronc.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-04-30" publication-format="electronic"><day>30</day><month>04</month><year>2026</year></pub-date><volume>25</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>28</fpage><lpage>40</lpage><history><date date-type="received" iso-8601-date="2026-04-27"><day>27</day><month>04</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-04-27"><day>27</day><month>04</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, АБВ-пресс</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://bioterapevt.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/1615">https://bioterapevt.abvpress.ru/jour/article/view/1615</self-uri><abstract xml:lang="en"><p><bold>Background</bold>. Lipophilicity is one of the most significant and widely used physico-chemical characteristics of a drug, which determines its path in the body.</p> <p><bold>Aim</bold>. To systematize and generalize the literature data on the main parameters of lipophilicity and methods of its determination.</p> <p><bold>Materials and methods</bold>. The search for materials on the subject under study was carried out using the following search and information and library databases: PubMed, CyberLeninka, eLibrary, ResearchGate. The search for publications was carried out by keywords / phrases: “lipophilicity”, “lipophilicity of drugs”, “octanol / water distribution coefficient”, “assessment of lipophilicity”, etc.</p> <p><bold>Results</bold>. Lipophilicity shows the affinity of a compound to a lipophilic medium, and is traditionally expressed as the logarithm of the distribution coefficient of a molecule between two immiscible liquids − an organic solvent and water. There are various approaches to assessing lipophilicity. The standard method is “shaking in a flask”, which is based on the extraction of the test substance in the octanol-water system. Alternatively, reverse-phase thin-layer chromatography or high-performance liquid chromatography is used to assess lipophilicity. Chromatographic methods make it possible to determine the lipophilicity of a wide range of newly synthesized compounds and are characterized by low cost of experiments, simplicity and high accuracy. For ionized compounds, it is possible to use potentiometric approaches that are based on potentiometric titration or potential measurement through the use of ion-selective electrodes. Computational methods that provide quick information on lipophilicity are usually used for screening chemical libraries and have significant advantages over experimental methods. Many programs have been developed to calculate the logarithm of the distribution coefficient, which are freely available both in the form of software and on online platforms.</p> <p><bold>Conclusion</bold>. This review provides basic information about lipophilicity, describes key parameters and criteria for its assessment, and presents modern approaches to determining this characteristic.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. Липофильность – oдна из наиболее значимых физико-химических характеристик лекарственного средства, определяющих его путь в организме.</p> <p><bold>Цель исследования</bold> – систематизировать и обобщить данные литературы об основных параметрах липофильности и методах ее определения.</p> <p><bold>Материалы и методы</bold>. Поиск материалов по исследуемой тематике проводили с использованием поисково-информационных и библиотечных баз данных: PubMed, CyberLeninka, eLibrary, ResearchGate. Поиск осуществляли по ключевым словам / словосочетаниям: «липофильность» (lipophilicity), «липофильность лекарственных препаратов» (lipophilicity of drugs), «коэффициент распределения октанол / вода» (octanol / water distribution coefficient), «оценка липофильности» (assessment of lipophilicity) и др.</p> <p><bold>Результаты</bold>. Липофильность показывает сродство соединения к липофильной среде и выражается традиционно в виде логарифма коэффициента распределения вещества между двумя несмешивающимися жидкостями – органическим растворителем и водой (logP). Стандартным является метод «встряхивание в колбе», который основан на экстракции исследуемого вещества в системе «октанол–вода». В качестве альтернативных для оценки липофильности используют хроматографические методы – обращенно-фазовую тонкослойную или высокоэффективную жидкостную хроматографию, которые позволяют определять липофильность вновь синтезированных соединений и характеризуются низкой стоимостью, простотой и высокой точностью. Для ионизированных соединений возможно применение потенциометрического титрования или измерение потенциала с использованием ионселективных электродов. Вычислительные методы, которые предоставляют быструю информацию о липофильности и обычно используют для скрининга химических библиотек, имеют значительные преимущества по сравнению с экспериментальными.</p> <p><bold>Заключение</bold>. В обзоре представлены базовые сведения о липофильности, описаны важнейшие параметры и критерии ее оценки, а также приведены современные подходы к определению данной характеристики.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lipophilicity</kwd><kwd>distribution coefficient</kwd><kwd>flask shaking</kwd><kwd>octanol – water system</kwd><kwd>lipophilicity assessment method</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>липофильность</kwd><kwd>коэффициент распределения</kwd><kwd>встряхивание в колбе</kwd><kwd>система октанол – вода</kwd><kwd>метод оценки липофильности</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Morak-Młodawska B., Jeleń M. Lipophilicity and pharmacokinetic properties of new anticancer dipyridothiazine with 1,2,3-triazole substituents. Molecules 2022;27(4):1253. DOI: 10.3390/molecules27041253</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Morak-Młodawska B., Jeleń M., Martula E., Korlacki R. Study of lipophilicity and ADME properties of 1,9-diazaphenothiazines with anticancer action. Int J Mol Sci 2023;24(8):6970. DOI: 10.3390/ijms24086970</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kempińska D., Chmiel T., Kot-Wasik A. et al. State of the art and prospects of methods for determination of lipophilicity of chemical compounds. TrAC 2019;113:54–73. DOI: 10.1016/j.trac.2019.01.011</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Klimoszek D., Jeleń M., Dołowy M. et al. Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents. Pharmaceuticals 2024;17(6):725. DOI: 10.3390/ph17060725</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bruno C.D., Harmatz J.S., Duan S.X. et al. Effect of lipophilicity on drug distribution and elimination: influence of obesity. Br J Clin Pharmacol 2021;87(8):3197–205. DOI: 10.1111/bcp.14735</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kisiel-Nawrot E., Pindjakova D., Latocha M. et al. Design, synthesis and antimicrobial properties of new tetracyclic quinobenzothiazine derivatives. Int J Mol Sci 2022;23(23):15078. DOI: 10.3390/ijms232315078</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wang Y., Xiong J., Xiao F. et al. LogD7.4 prediction enhanced by transferring knowledge from chromatographic retention time, microscopic pKa and logP. J Cheminform 2023;15(1):76. DOI: 10.1186/s13321-023-00754-4</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Roy D., Patel C. Revisiting the use of quantum chemical calculations in LogP octanol-water prediction. Molecules 2023;28(2):801. DOI: 10.3390/molecules28020801</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Tafreshi N.K., Kil H., Pandya D.N. et al. Lipophilicity determines routes of uptake and clearance, and toxicity of an alpha-particle-emitting peptide receptor radiotherapy. ACS Pharmacol Transl Sci 2021;4(2):953–65. DOI: 10.1021/acsptsci.1c00035</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mehta K., Maass C., Cucurull-Sanchez L. et al. Modernizing preclinical drug development: the role of new approach methodologies. ACS Pharmacol Transl Sci 2025;8(6):1513–25. DOI: 10.1021/acsptsci.5c00162</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Cecere G., Guasch L., Olivares-Morales A.M. et al. LipMetE (lipophilic metabolism efficiency) as a simple guide for half-life and dosing regimen prediction of oral drugs. ACS Med Chem Lett 2022;13(9):1444–51. DOI: 10.1021/acsmedchemlett.2c00183</mixed-citation></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Skotnikov A.S., Melnik M.V., Zinina E.A., Sivertseva I.V. Contribution of lipophilicity to the clinical effects of drugs. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology 2024;29(3):5829. (In Russ.). DOI: 10.15829/1560-4071-2024-5829</mixed-citation><mixed-citation xml:lang="ru">Скотников А.С., Мельник М.В., Зинина Е.А., Сиверцева И.В. Вклад липофильности в клинические эффекты лекарственного препарата. Российский кардиологический журнал 2024;29(3):5829. DOI: 10.15829/1560-4071-2024-5829</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><mixed-citation>Spielvogel C.P., Schindler N., Schröder C. et al. Enhancing blood-brain barrier penetration prediction by machine learning-based integration of novel and existing, in silico and experimental molecular parameters from a standardized database. J Chem Inf Model 2025;65(6):2773–84. DOI: 10.1021/acs.jcim.4c02212</mixed-citation></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Krivorotov D.V., Kochura D.M., Dulov S.A., Radilov A.S. Experimental comparing of lipophilicity of opioid antagonists. Toksikologicheskiy vestnik = Toxicological Review 2022;30(3):149–57. (In Russ.). DOI: 10.47470/0869-7922-2022-30-3-149-157</mixed-citation><mixed-citation xml:lang="ru">Криворотов Д.В., Кочура Д.М., Дулов С.А., Радилов А.С. Экспериментальное сравнение липофильности антагонистов опиоидов. Токсикологический вестник 2022;30(3): 149–57. DOI: 10.47470/0869-7922-2022-30-3-149-157</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Kataeva N.N., Naronova N.A., Golitsyna K.O. et al. Evaluation on cephalosporin’s lipophilic properties. Izv. Vyssh. Uchebn. Zaved. Khim. Khim. Technol. = ChemChemTech 2024; 67(7):55–62. (In Russ.). DOI: 10.6060/ivkkt.20246707.7018</mixed-citation><mixed-citation xml:lang="ru">Катаева Н.Н., Наронова Н.А., Голицына К.О. и др. Оценка липофильных свойств антибиотиков группы цефалоспоринов. Изв. вузов. Химия и хим. технология 2024;67(7):55–62. DOI: 10.6060/ivkkt.20246707.7018</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><mixed-citation>Kotta-Loizou I., Pritsa A., Antasouras G. et al. Fetus exposure to drugs and chemicals: a holistic overview on the assessment of their transport and metabolism across the human placental barrier. Diseasas 2024;12(6):114. DOI: 10.3390/diseases12060114</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Li Z., Wu Y., Zeng S. et al. Strategy advancements in placental pharmacokinetics: from in vitro experiments to in silico prediction. Front Pharmacol 2025;16:1694886. DOI: 10.3389/fphar.2025.1694886</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Seethamraju S.M., Nori L.P. Obstruction and approaches to cross the drug molecules through blood retinal barrier: an overview. Pharmacophore 2024;15(4):20–32. DOI: 10.51847/3HHVJkjhAj</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Manzari M.T., Shamay Y., Kiguchi H. et al. Targeted drug delivery strategies for precision medicines. Nat Rev Mater 2021;6:351–70. DOI: 10.1038/s41578-020-00269</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>O’Donovan D.H., De Fusco C., Kuhnke L., Reichel A. Trends in molecular properties, bioavailability, and permeability across the bayer compound collection. J Med Chem 2023;66(4):2347–60. DOI: 10.1021/acs.jmedchem.2c01577</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Soares A.C.G., Sousa G.H.M., Calil R.L., Trossini G.H.G. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Mol Inform 2023;42: e202300115. DOI: 10.1002/minf.202300115</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tsantili-Kakoulidou A., Demopoulos V.J. Drug-like properties and fraction lipophilicity index as a combined metric. ADMET DMPK 2021;9(3):177–90. DOI: 10.5599/admet.1022</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Leeson P.D., Bento A.P., Gaulton A. et al. Target-based evaluation of “drug-like” properties and ligand efficiencies. J Med Chem 2021;64(11):7210–30. DOI: 10.1021/acs.jmedchem.1c00416</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Soares J.X., Santos Á., Fernandes C., Pinto M.M.M. Liquid chromatography on the different methods for the determination of lipophilicity: an essential analytical tool in medicinal chemistry. Chemosensors 2022;10:340. DOI: 10.3390/chemosensors10080340</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Rutkowska E., Pajak K., Jóźwiak K. Lipophilicity – methods of determination and its role in medicinal chemistry. Acta Pol Pharm 2013;70(1):3–18.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Starek M., Plenis A., Zagrobelna M., Dąbrowska M. Assessment of lipophilicity descriptors of selected NSAIDs obtained at different TLC stationary phases. Pharmaceutics 2021;13(4):440. DOI: 10.3390/pharmaceutics13040440</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Giannopoulos G.I. Fullerene derivatives for drug delivery against COVID-19: a molecular dynamics investigation of dendro[60]fullerene as nanocarrier of Molnupiravir. Nanomaterials (Basel) 2022;12(15):2711. DOI: 10.3390/nano12152711</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Pusztai G., Poszávácz L., Vincze Anna et al. Thiadiazino-indole, thiadiazino-carbazole and benzothiadiazino-carbazole dioxides: synthesis, physicochemical and early ADME characterization of representatives of new tri-, tetra- and pentacyclic ring systems and their intermediates. Beilstein J Org Chem 2025;21:2220–33. DOI: 10.3762/bjoc.21.169</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Leśnikowski Z.J., Ekholm F., Hosmane N.S. et al. Early stage in vitro bioprofiling of potential low-molecular-weight organoboron compounds for boron neutron capture therapy (BNCT)-proposal for a guide. Cells 2024;13(10):798. DOI: 10.3390/cells13100798</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Waring M.J. Defining optimum lipophilicity and molecular weight ranges for drug candidates – molecular weight dependent lower logD limits based on permeability. Bioorg Med Chem Lett 2009;19(10):2844–51. DOI: 10.1016/j.bmcl.2009.03.109</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ciura K., Fedorowicz J., Andrić F. et al. Lipophilicity determination of antifungal isoxazolo[3,4-b]pyridin-3(1H)-ones and their N1-substituted derivatives with chromatographic and computational methods. Molecules 2019;24(23):4311. DOI: 10.3390/molecules24234311</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Jia Q., Ni Y., Liu Z. et al. Fast prediction of lipophilicity of organofluorine molecules: deep learning-derived polarity characters and experimental tests. J Chem Inf Model 2022; 62(20):4928–36. DOI: 10.1021/acs.jcim.2c01201</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Sima I.A., Kot-Wasik A., Wasik A. et al. Assessment of lipophilicity indices derived from retention behavior of antioxidant compounds in RP-HPLC. Molecules 2017;22(4):550. DOI: 10.3390/molecules22040550</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Katz D., Fike K., Longenberger J. et al. AlphaLogD determination: an optimized reversed-phase liquid chromatography method to measure lipophilicity on neutral and basic small and beyond-rule-of-five compounds. J Chromatogr A 2022;1674:463146. DOI: 10.1016/j.chroma.2022.463146</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Lovison D., Alessi D., Allegri L. et al. Enantioselective cytotoxicity of chiral diphosphine ruthenium (II) complexes against cancer cells. Chemistry 2022;28(33):e202200200. DOI: 10.1002/chem.202200200</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Grada A., Del Rosso J.Q., Moore A.Y. et al. Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity. Front Med (Lausanne) 2022;9:1033980. DOI: 10.3389/fmed.2022.1033980</mixed-citation></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Kulikova T.I., Kuznetsova O.V., Arseniev M.V. Estimation of lipophilicity parameters of 3,5-di-tert-butylpyrocatechol by reverse phase HPLC. Sorbtsionnye i khromatograficheskie protsessy = Sorption and Chromatographic Processes 2023;23(3):405–12. (In Russ.). DOI: 10.17308/sorpchrom.2023.23/11320</mixed-citation><mixed-citation xml:lang="ru">Куликова Т.И., Кузнецова О.В., Арсеньев М.В. Оценка параметров липофильности производных 3,5-ди-трет-бутилпирокатехина методом ВЭЖХ с обращенной фазой. Сорбционные и хроматографические процессы 2023;23(3):405–12. DOI: 10.17308/sorpchrom.2023.23/11320</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><mixed-citation>Bullerjahn J.T., Hanson S.M. Extracting thermodynamic properties from Van’t Hoff plots with emphasis on temperature-sensing ion channels. Temperature (Austin) 2023;11(1):60–71. DOI: 10.1080/23328940.2023.2265962</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Gampe N., Dávid D.N., Takács-Novák K. et al. In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system. PLoS One 2022;17(3):e0265639. DOI: 10.1371/journal.pone.0265639</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Makuch E., Nowak A., Günther A. et al. Enhancement of the antioxidant and skin permeation properties of eugenol by the esterification of eugenol to new derivatives. AMB Express 2020;10(1):187. DOI: 10.1186/s13568-020-01122-3</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Islam M.S., Mitra S. Synthesis of microwave functionalized, nanostructured polylactic co-glycolic acid (nfPLGA) for incorporation into hydrophobic dexamethasone to enhance dissolution. Nanomaterials (Basel) 2023;13(5):943. DOI: 10.3390/nano13050943</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Jiang Y., Tian Y., Feng B. et al. A novel molecular imaging probe [99mTc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts. Sci Rep 2023;13(1):3700. DOI: 10.1038/s41598-023-30806-6</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Annunziata A., Imbimbo P., Cucciolito M.E. et al. Impact of hydrophobic chains in five-coordinate glucoconjugate Pt(II) anticancer agents. Int J Mol Sci 2023;24(3):2369. DOI: 10.3390/ijms24032369</mixed-citation></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Shprakh Z.S., Ignateva E.V., Kraeva M.N. et al. Experimental study of somatostatin analogue cyphetrylin lipophilicity. Rossijskij bioterapevticeskij zurnal = Russian Journal of Biotherapy 2024;23(4):77–82. (In Russ.). DOI: 10.17650/1726-9784-2024-23-4-77-82</mixed-citation><mixed-citation xml:lang="ru">Шпрах З.С., Игнатьева Е.В., Краева М.Н. и др. Экспериментальное исследование липофильности аналога соматостатина цифетрилина. Российский биотерапевтический журнал 2024;23(4):77–82. DOI: 10.17650/1726-9784-2024-23-4-77-82</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><mixed-citation>Andrés A., Rosés M., Ràfols C. et al. Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts. Eur J Pharm Sci 2015;30(76):181–91. DOI: 10.1016/j.ejps.2015.05.008</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Dołowy M., Jampilek J., Bober-Majnusz K. A comparative study of the lipophilicity of metformin and phenformin. Molecules 2021;26(21):6613. DOI: 10.3390/molecules26216613</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Bertsch E., Suñer S., Pinheiro S., Zamora WJ. Critical assessment of pH-dependent lipophilicity profiles of small molecules: which one should we use and in which cases? Chemphyschem 2023;24(24):e202300548. DOI: 10.1002/cphc.202300548</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Constantinescu T., Lungu C.N., Lung I. Lipophilicity as a central component of drug-like properties of chalchones and flavonoid derivatives. Molecules 2019;24(8):1505. DOI: 10.3390/molecules24081505</mixed-citation></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Port A., Bordas M., Enrech R. et al. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (logPo/w) of neutral, acidic, basic, amphoteric, and zwitterionic drugs. Eur J Pharm Sci 2018;122:331–40. DOI: 10.1016/j.ejps.2018.07.010</mixed-citation><mixed-citation xml:lang="ru">Port A., Bordas M., Enrech R. et al. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (<math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mi>log</mi><msub><mi>P</mi><mrow><mn>0</mn><mo>/</mo><mi>w</mi></mrow></msub></math>) of neutral, acidic, basic, amphoteric, and zwitterionic drugs. Eur J Pharm Sci 2018;122:331–40. DOI: 10.1016/j.ejps.2018.07.010</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><mixed-citation>Bertsch‐Aguilar E., Piedra A., Acuña D. et al. LiProS: findable, accessible, interoperable, and reusable data simulation workflow to predict accurate lipophilicity profiles for small molecules. Mol Inform 2025;44(8):e202500136. DOI: 10.1002/minf.70007</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Barzanti C., Evans R., Fouquet J. et al. Potentiometric determination of octanol–water and liposome–water partition coefficients (logP) of ionizable organic compounds. Tetrahedron Letters 2007;48(19):3337–41. DOI: 10.1016/j.tetlet.2007.03.085</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Ciura K., Dziomba S., Nowakowska J., Markuszewski M.J. Thin layer chromatography in drug discovery process. J Chromatogr A 2017;1520:9–22. DOI: 10.1016/j.chroma.2017.09.015</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Dąbrowska M., Starek M., Chłoń-Rzepa G. et al. Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity. Bioorg Med Chem Lett 2021;49:128318. DOI: 10.1016/j.bmcl.2021.128318</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Wardecki D., Dołowy M., Bober-Majnusz K., Jampilek J. Comparative study of the lipophilicity of selected anti-androgenic and blood uric acid lowering compounds. Molecules 2022;28(1):166. DOI: 10.3390/molecules28010166</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>OECD. Test No. 117: Partition coefficient (n-octanol/water), HPLC Method. Paris: OECD Publishing, 2022.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Liang C., Lian H. Recent advances in lipophilicity measurement by reversed-phase high-performance liquid chromatography. TrAC Trends in Analytical Chemistry 2015;68:28–36. DOI: 10.1016/j.trac.2015.02.009</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Paw B., Rafał Ś., Łukasz K. et al. Comparison of HPLC, HPTLC, and in silico lipophilicity parameters determined for 5-heterocyclic 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Molecules 2024;29(11):2478. DOI: 10.3390/molecules29112478</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Georgieva S., Voyslavov T., Chanev C., Petrov O. High-performance liquid chromatography-based evaluation of lipophilicity of a series of novel stilbene derivatives. Pharmacia 2025;72(1–8):e141364. DOI: 10.3897/pharmacia.72.e141364</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Plachká K., Pilařová V., Gazárková T. et al. Advancing fundamental understanding of retention interactions in supercritical fluid chromatography using artificial neural networks: polar stationary phases with -OH moieties. Anal Chem 2024;96(31):12748–59. DOI: 10.1021/acs.analchem.4c01811</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Sobczak Ł., Kołodziej D., Goryński K. Benefits of innovative and fully water-compatible stationary phases of thin-film microextraction (TFME) blades. Molecules 2021;26(15):4413. DOI: 10.3390/molecules26154413</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Coutinho A.L., Cristofoletti R., Wu F. et al. Relative performance of volume of distribution prediction methods for lipophilic drugs with uncertainty in LogP value. Pharm Res 2024;41(6):1121–38. DOI: 10.1007/s11095-024-03703-4</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Kovačević S.Z., Karadžić Banjac M.Ž., Podunavac-Kuzmanović S.O. et al. Comprehensive chemometric and chromatographic investigation of lipophilicity of biologically active androstane-3-oxime derivatives across diverse UHPLC systems. Pharmaceuticals 2025;18(12):1778. DOI: 10.3390/ph18121778</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Liang C., Qiao J., Lian H. Determination of reversed-phase high performance liquid chromatography based octanol-water partition coefficients for neutral and ionizable compounds: methodology evaluation. J Chromatogr A 2017;1528:1–16. DOI: 10.1016/j.chroma.2017.10.064</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Ganesh V., Basuri P., Sahini K., Nalini C.N. Retention behaviour of analytes in reversed-phase high-performance liquid chromatography – a review. Biomed Chromatogr 2023;37(7):e5482. DOI: 10.1002/bmc.5482</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Saranjam L., Nedyalkova M., Fuguet E. et al. Collection of partition coefficients in hexadecyltrimethylammonium bromide, sodium cholate, and lithium perfluorooctanesulfonate micellar solutions: experimental determination and computational predictions. Molecules 2023;28(15):5729. DOI: 10.3390/molecules28155729</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Redka M., Baumgart S., Kupczyk D. et al. Lipophilic studies and in silico ADME profiling of biologically active 2-aminothiazol-4(5H)-one derivatives. Int J Mol Sci 2023;24(15):12230. DOI: 10.3390/ijms241512230</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Klimoszek D., Dołowy M., Jeleń M., Bober-Majnusz K. Use of TLC and computational methods to determine lipophilicity parameters of selected neuroleptics: comparison of experimental and theoretical studies. Pharmaceuticals 2025;18(9):1255. DOI: 10.3390/ph18091255</mixed-citation></ref></ref-list></back></article>
